Bilirubin and postpartum depression: an observational and Mendelian randomization study.

Yi Liu, Zhihao Wang, Duo Li, Bin Lv
Author Information
  1. Yi Liu: Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
  2. Zhihao Wang: Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
  3. Duo Li: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
  4. Bin Lv: Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.

Abstract

Background: Postpartum depression (PPD) is one of the most common complications of delivery and is usually disregarded. Several risk factors of PPD have been identified, but its pathogenesis has not been completely understood. Serum bilirubin has been found to be a predictor of depression, whose relationship with PPD has not been investigated.
Methods: Observational research was performed followed by a two-sample Mendelian randomization (MR) analysis. From 2017 to 2020, the clinical data of pregnant women were retrospectively extracted. Logistic regression and random forest algorithm were employed to assess the risk factors of PPD, including the serum levels of total bilirubin and direct bilirubin. To further explore their potential causality, univariable and multivariable Mendelian randomization (MVMR) were conducted. Sensitivity analyses for MR were performed to test the robustness of causal inference.
Results: A total of 1,810 patients were included in the PPD cohort, of which 631 (34.87%) were diagnosed with PPD. Compared with the control group, PPD patients had a significantly lower level of total bilirubin (9.2 μmol/L, IQR 7.7, 11.0 in PPD; 9.7 μmol/L, IQR 8.0, 12.0 in control, < 0.001) and direct bilirubin (2.0 μmol/L, IQR 1.6, 2.6 in PPD; 2.2 μmol/L, IQR 1.7, 2.9 in control, < 0.003). The prediction model identified eight independent predictive factors of PPD, in which elevated total bilirubin served as a protective factor (OR = 0.94, 95% CI 0.90-0.99, = 0.024). In the MR analyses, genetically predicted total bilirubin was associated with decreased risk of PPD (IVW: OR = 0.86, 95% CI 0.76-0.97, = 0.006), which remained consistent after adjusting educational attainment, income, and gestational diabetes mellitus. Conversely, there is a lack of solid evidence to support the causal relationship between PPD and bilirubin.
Conclusion: Our results suggested that decreased total bilirubin was associated with the incidence of PPD. Future studies are warranted to investigate its potential mechanisms and illuminate the pathogenesis of PPD.

Keywords

References

  1. J Hepatol. 2021 Dec;75(6):1485-1490 [PMID: 34153399]
  2. Psychiatry Clin Neurosci. 2013 May;67(4):259-64 [PMID: 23683157]
  3. Cells. 2021 Sep 13;10(9): [PMID: 34572050]
  4. Int J Epidemiol. 2019 Jun 1;48(3):713-727 [PMID: 30535378]
  5. Stat Methods Med Res. 2012 Jun;21(3):223-42 [PMID: 21216802]
  6. J Hepatol. 2016 Apr;64(4):933-45 [PMID: 26658682]
  7. Front Psychiatry. 2021 Jun 25;12:685656 [PMID: 34248718]
  8. Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1335-45 [PMID: 23248031]
  9. Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):995-1010 [PMID: 29941659]
  10. Antioxidants (Basel). 2022 Jul 18;11(7): [PMID: 35883877]
  11. N Engl J Med. 2016 Dec;375(22):2177-2186 [PMID: 27959754]
  12. Genet Epidemiol. 2013 Nov;37(7):658-65 [PMID: 24114802]
  13. BMJ Open. 2021 Sep 30;11(9):e052008 [PMID: 34593503]
  14. Int J Epidemiol. 2017 Oct 5;47(1):29-35 [PMID: 29040602]
  15. Nature. 1985 Apr 25-May 1;314(6013):734-6 [PMID: 4039415]
  16. Front Psychiatry. 2021 Nov 29;12:731220 [PMID: 34912246]
  17. Psychiatry Res. 2007 Oct 31;153(2):203-7 [PMID: 17719094]
  18. Nat Genet. 2021 Feb;53(2):185-194 [PMID: 33462484]
  19. Psychiatry Clin Neurosci. 2018 Jul;72(7):513-521 [PMID: 29603506]
  20. J Affect Disord. 2016 Dec;206:189-203 [PMID: 27475890]
  21. J Affect Disord. 2019 Dec 1;259:392-403 [PMID: 31470184]
  22. Psychoneuroendocrinology. 2017 Feb;76:197-205 [PMID: 27960139]
  23. Int J Epidemiol. 2020 Jun 1;49(3):762-763g [PMID: 32374401]
  24. Elife. 2018 May 30;7: [PMID: 29846171]
  25. Int J Epidemiol. 2015 Apr;44(2):512-25 [PMID: 26050253]
  26. Nat Genet. 2018 May;50(5):693-698 [PMID: 29686387]
  27. J Affect Disord. 2018 Mar 1;228:143-152 [PMID: 29248820]
  28. PLoS One. 2016 Feb 05;11(2):e0148195 [PMID: 26848571]
  29. J Affect Disord. 2014 Sep;166:124-31 [PMID: 25012420]
  30. Annu Rev Med. 2019 Jan 27;70:183-196 [PMID: 30691372]
  31. Curr Epidemiol Rep. 2018;5(3):214-220 [PMID: 30148040]
  32. Drug Discov Today. 2020 Jul;25(7):1270-1276 [PMID: 32404275]
  33. Stat Med. 2008 Apr 15;27(8):1133-63 [PMID: 17886233]
  34. Stat Med. 2021 Nov 10;40(25):5434-5452 [PMID: 34338327]
  35. J Epidemiol. 2023 May 5;33(5):209-216 [PMID: 34334503]
  36. Front Psychiatry. 2018 Feb 01;8:248 [PMID: 29449816]
  37. Nature. 2018 Oct;562(7726):203-209 [PMID: 30305743]
  38. Nature. 2016 May 11;533(7604):539-42 [PMID: 27225129]
  39. Br J Psychiatry. 1987 Jun;150:782-6 [PMID: 3651732]
  40. Biol Psychiatry. 2002 Mar 1;51(5):422-5 [PMID: 11904137]
  41. BMC Womens Health. 2014 May 14;14:67 [PMID: 24886024]
  42. J Endocrinol Invest. 2020 Mar;43(3):271-277 [PMID: 31552596]
  43. JAMA Psychiatry. 2013 May;70(5):490-8 [PMID: 23487258]
  44. J Affect Disord. 2019 Jun 15;253:292-302 [PMID: 31077972]
  45. Lancet. 2014 Nov 15;384(9956):1775-88 [PMID: 25455248]
  46. Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E191-E207 [PMID: 33284088]
  47. Neuropsychiatr Dis Treat. 2017 Dec 27;14:83-93 [PMID: 29343960]
  48. Heliyon. 2020 Jan 07;6(1):e03138 [PMID: 32042943]
  49. Clin Sci (Lond). 2015 Jul;129(1):1-25 [PMID: 25881719]
  50. Science. 1987 Feb 27;235(4792):1043-6 [PMID: 3029864]
  51. BMC Psychiatry. 2019 Dec 27;19(1):419 [PMID: 31882000]

Word Cloud

Created with Highcharts 10.0.0PPD0bilirubintotal2riskfactorsMendelianrandomizationμmol/LIQR7=depressionMR1control9identifiedpathogenesisrelationshipperformedserumdirectpotentialanalysescausalpatients<6OR95%CIassociateddecreasedpostpartumBackground:PostpartumonecommoncomplicationsdeliveryusuallydisregardedSeveralcompletelyunderstoodSerumfoundpredictorwhoseinvestigatedMethods:Observationalresearchfollowedtwo-sampleanalysis20172020clinicaldatapregnantwomenretrospectivelyextractedLogisticregressionrandomforestalgorithmemployedassessincludinglevelsexplorecausalityunivariablemultivariableMVMRconductedSensitivitytestrobustnessinferenceResults:810includedcohort6313487%diagnosedComparedgroupsignificantlylowerlevel11812001003predictionmodeleightindependentpredictiveelevatedservedprotectivefactor9490-099024geneticallypredictedIVW:8676-097006remainedconsistentadjustingeducationalattainmentincomegestationaldiabetesmellitusConverselylacksolidevidencesupportConclusion:resultssuggestedincidenceFuturestudieswarrantedinvestigatemechanismsilluminateBilirubindepression:observationalstudyoxidativestress

Similar Articles

Cited By